US Stock MarketDetailed Quotes

TSHA Taysha Gene Therapies

Watchlist
  • 2.4950
  • -0.1150-4.41%
Trading Dec 4 10:27 ET
511.33MMarket Cap3.96P/E (TTM)

Taysha Gene Therapies Key Stats

Business Currency:USD
2024/Q3
Stock NameRevenueRatio
Business of developing AAV-based gene therapies for the treatment of rare monogenic diseases of the1.79M100.00%
Region Currency:USD
2023/FY
Stock NameRevenueRatio
United States15.45M100.00%